1.
Teich K, Krzykalla J, Kapp-Schwoerer S, Gaidzik VI, Schlenk RF, Paschka P, Weber D, Fiedler W, Kühn MW, Schroeder T, Mayer K, Lübbert M, Ramachandran D, Benner A, Ganser A, Döhner H, Heuser M, Döhner K, Thol F. Cluster of differentiation 33 single nucleotide polymorphism rs12459419 is a predictive factor in patients with <i>nucleophosmin1</i&gt;-mutated acute myeloid leukemia receiving gemtuzumab ozogamicin. haematol [Internet]. 2021May27 [cited 2021Dec.9];106(11):2986-9. Available from: https://haematologica.org/article/view/haematol.2021.278894